412 participants
Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-10-03
- Start Date:
- 2026-01-01
- Completion:
- 2028-12-31
Conditions
- Amyotrophic Lateral Sclerosis (ALS)
Interventions
- DRUG
No Results Yet